Cardiac safety of pembrolizumab-based neoadjuvant chemoimmunotherapy in early triple-negative breast cancer: real-world experience from a single centre
19 June 2026 (08:30 - 17:30)
Organised by: 
Abstract
Slides
About the speaker
University Hospital Sestre Milosrdnice, Zagreb (Croatia)
45 More presentations in this session
Mrs A. Stephanus (Brasilia, BR)
Doctor Z. Sandor (Budapest, HU)
Mr T. Uyl (Rotterdam, NL)
Access the full session
The Event
ESC Cardio-Oncology 2026
19 June 2026
08:30 CET
You may be interested in
Congress Presentation
ESC Journals
Congress Presentation
Congress Presentation
